Documente Academic
Documente Profesional
Documente Cultură
Overview
• Concepts, classification, biology
• Epidemiology
• Clinical presentation
• Diagnosis
• Staging
• Three important types of lymphoma
Conceptualizing lymphoma
• neoplasms of lymphoid origin, typically
causing lymphadenopathy
• leukemia vs lymphoma
• lymphomas as clonal expansions of
cells at certain developmental stages
ALL CLL Lymphomas MM
naïve
B-lymphocytes
Plasma
Lymphoid cells
progenitor T-lymphocytes
Eosinophils
Basophils
Monocytes
Platelets
Red cells
B-cell development
memory
B-cell
stem CLL germinal
cell mature center
naive B-cell
B-cell
lymphoid
progenitor
progenitor-B
MM
ALL
pre-B DLBCL,
immature FL, HL
B-cell plasma cell
Classification
– precursor
– mature
• Hodgkin lymphoma
A practical way to think of lymphoma
Category Survival of Curability To treat or
untreated not to treat
patients
70
60 lung
colorectal
50 breast
40
30
20 NHL
10 Hodgkin
lymphoma
0
1985 1990 1995 2000
Year
Incidence/100,000/annum
20
40
60
80
100
0
0-1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
Canada
Age (years)
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85+
Age distribution of new NHL cases in
incidence/100,000/annum
0
1
2
3
4
5
6
0-1
1-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
Age (years)
55-59
60-64
65-69
70-74
75-79
80-84
85+
lymphoma cases in Canada
Age distribution of new Hodgkin
Risk factors for NHL
• immunosuppression or immunodeficiency
• connective tissue disease
• family history of lymphoma
• infectious agents
• ionizing radiation
Clinical manifestations
• Variable
• severity: asymptomatic to extremely ill
• time course: evolution over weeks, months, or
years
• Systemic manifestations
• fever, night sweats, weight loss, anorexia, pruritis
• Local manifestations
• lymphadenopathy, splenomegaly most common
• any tissue potentially can be infiltrated
Other complications of
lymphoma
• bone marrow failure (infiltration)
• CNS infiltration
• immune hemolysis or thrombocytopenia
• compression of structures (eg spinal
cord, ureters)
• pleural/pericardial effusions, ascites
Diagnosis requires an
adequate biopsy
• Diagnosis should be biopsy-proven
before treatment is initiated
• Need enough tissue to assess cells and
architecture
– open bx vs core needle bx vs FNA
Staging of lymphoma
Stage I Stage II Stage III Stage IV
A: absence of B symptoms
B: fever, night sweats, weight loss
Three common lymphomas
• Follicular lymphoma
• Diffuse large B-cell lymphoma
• Hodgkin lymphoma
Relative frequencies of different
lymphomas
Non-Hodgkin Lymphomas
Thomas Hodgkin
(1798-1866)
Classical Hodgkin Lymphoma
Hodgkin lymphoma
• cell of origin: germinal centre B-cell
• Reed-Sternberg cells (or RS variants) in
the affected tissues
• most cells in affected lymph node are
polyclonal reactive lymphoid cells, not
neoplastic cells
Reed-Sternberg cell
RS cell and variants
cytokines
germinal
centre RS cell
inflammatory
B cell
response
Hodgkin lymphoma
Histologic subtypes
• Classical Hodgkin lymphoma
– nodular sclerosis (most common subtype)
– mixed cellularity
– lymphocyte-rich
– lymphocyte depleted
Epidemiology
• less frequent than non-Hodgkin
lymphoma
• overall M>F
• peak incidence in 3rd decade
Associated (etiological?)
factors
• EBV infection
• smaller family size
• higher socio-economic status
• caucasian > non-caucasian
• possible genetic predisposition
• other: HIV? occupation? herbicides?
Clinical manifestations:
• lymphadenopathy
• contiguous spread
• extranodal sites relatively uncommon
except in advanced disease
• “B” symptoms
Treatment and Prognosis
Stage Treatment Failure- Overall 5
free year
survival survival
I,II ABVD x 4 70-80% 80-90%
& radiation